CELL INTELLIGENCE · 肿瘤细胞治疗研究

CAR-T 与非 CAR-T 桥接策略在复发/难治性 B 细胞急性淋巴细胞白血病异基因造血干细胞移植前的比较：一项系统综述

CAR-T Versus Non-CAR-T Bridging Strategies Before Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Acute Lymphoblastic

一项研究报告，CAR-T 桥接后的累积复发率（CIR）显著更低，无病生存期（DFS）更高（18.9% vs.

多模式 C9-66 CAR-T 细胞免疫疗法改善胰腺癌临床前模型的结局

Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer.

C9-66 CAR-T 细胞经代谢优化与 TME 重编程，代表一种肿瘤特异性、可临床转化的免疫治疗策略，适用于 PDAC 及其他表达 ofCS 的实体瘤。

T 细胞与 NK 细胞在肿瘤免疫中的协同作用

Coordinated Roles of T Cells and Natural Killer Cells in Tumor Immunity.

CAR-T 治疗与自体造血干细胞移植后的长期认知功能障碍：倾向性评分匹配队列研究

Long-Term Cognitive Impairment After CAR-T Therapy Versus Autologous Stem Cell Transplantation: A Propensity Score-Matched Cohort Study.

树突状细胞介导的抗癌免疫中的蛋白酪氨酸激酶

Protein tyrosine kinases in dendritic cell-mediated anti-cancer immunity.

肺腺癌中自然杀伤（NK）细胞的表征及基于单细胞和大分子 RNA-seg 数据构建 NK 风险特征

Characterization of natural killer (NK) cells in lung adenocarcinoma and construction of an NK risk signature based on single-cell and macromolecular

基于 NK 细胞的风险特征被证明是预测 LUAD 患者预后的有价值工具。

肿瘤微环境在介导放射性药物治疗中的作用：连接核医学与肿瘤免疫治疗

The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy.

社论：树突状细胞在癌症免疫中重要性的新视角：从实验室到患者床边

Editorial: A new perspective on the importance of dendritic cells in cancer immunity: from bench to patient's bedside.

肺癌中的免疫细胞衔接器

Immune cell engagers in lung cancer.

基于 IL-15 的肿瘤免疫治疗进展及 IL-2 与 IL-15 通过共享 IL-2Rβγ 受体信号传导的不同免疫效应

Advances in IL-15-Based Cancer Immunotherapy and Divergent Immunological Effects of IL-2 and IL-15 Signaling via the Shared IL-2Rβγ Receptor.